US Patent Issued to NephroDI Therapeutics on Oct. 7 for "Substituted cycloalkanes for managing nephrogenic diabetes insipidus" (Georgia Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,858, issued on Oct. 7, was assigned to NephroDI Therapeutics Inc. (Seattle).

"Substituted cycloalkanes for managing nephrogenic diabetes insipidus" was invented by Jeff Sands (Atlanta), Janet Klein (Decatur, Ga.), Ish Khanna (Alpharetta, Ga.) and Sivaram Pillarisetti (Norcross, Ga.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In certain embodiments, this disclosure relates to methods of treating or preventing nephrogenic diabetes insipidus comprising administering an effective amount of compounds of the class of alkyl carboxylic acids, such as 1,1'-(decane-1,10-diyl)bis(cyclopropane-1-carboxylic acid), pharmaceutical salts or derivatives thereof, a...